SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Systems Endocrinology
This article is part of the Research TopicInterplay between Glucose and Lipid Homeostasis in Metabolic HealthView all 8 articles
Efficacy and Safety of Acupuncture-Related Therapies in Improving Insulin Resistance, Reproductive Endocrine Outcomes, and Ovarian Morphology in Polycystic Ovary Syndrome: A Systematic Review and Network Meta-Analysis
Provisionally accepted
- Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This network meta-analysis aimed to compare and rank the efficacy and safety of acupuncture-related therapies (ARTs) for polycystic ovary syndrome (PCOS) in improving insulin resistance (IR), reproductive endocrine outcomes, and ovarian morphology. Methods: Randomized controlled trials (RCTs) in Chinese and English were retrieved up to September 2025 from eight databases (the Cochrane Library, Web of Science, PubMed, Embase, VIP, CNKI, Wanfang, and CBM). Eligible participants were women with PCOS diagnosed using established international or Chinese criteria. Interventions compared ARTs (e.g., acupuncture, moxibustion, electroacupuncture) versus conventional medication and/or placebo. The primary outcome was homeostatic model assessment of IR (HOMA-IR). Secondary outcomes included fasting insulin (FINS), fasting blood glucose (FBG), body mass index (BMI), waist-to-hip ratio (WHR), testosterone (T), luteinizing hormone (LH), follicle-stimulating hormone (FSH), LH/FSH, antral follicle count (AFC), and ovarian volume (OV). Risk of bias was assessed using Review Manager 5.3, and network meta-analysis with surface under the cumulative ranking curve (SUCRA) rankings was conducted in Stata 17.0. All outcomes were summarized as mean differences (MDs) with 95% confidence intervals (CIs). Results: 53 RCTs involving 4,406 participants and 12 ART regimens (including two combined regimens) were included. Acupoint injection therapy (AIT) and acupuncture plus moxibustion (Acu + Moxi) significantly reduced HOMA-IR (MD=2.20, 95% CI 0.44-3.96; MD=1.06, 95% CI 0.28-1.84). AIT, catgut implantation at acupoint (CIAA), and Acu reduced FINS (MD=7.30, 95% CI 0.83-13.77; MD=3.11, 95% CI 1.97-4.25; MD=2.97, 95% CI 1.87-4.06). Acu + Moxi reduced BMI (MD=5.80, 95% CI 3.38-8.22), and electroacupuncture (EA) reduced WHR (MD=0.06, 95% CI 0.02-0.09). Laser acupuncture (LA) reduced T and LH (MD=0.59, 95% CI 0.33-0.85; MD=3.00, 95% CI 0.47-5.53). For ovarian morphology, warm needle therapy (WNT) and Acu reduced AFC (MD=4.08, 95% CI 0.63-7.53; MD=3.06, 95% CI 1.07-5.05), and Acu reduced ovarian volume (OV) (MD=2.38, 95% CI 0.67-4.08). Overall, Acu ranked among the top interventions across multiple outcomes. Most reported adverse events were non-serious and transient. Adverse-event reporting was limited across trials. Conclusion: ARTs may be safe and effective complementary therapies for improving IR, reproductive endocrine outcomes, and ovarian morphology in women with PCOS.
Keywords: Acupuncture-related therapies, Network meta-analysis, NMA, pcos, Polycystic Ovary Syndrome, Systematic review
Received: 18 Nov 2025; Accepted: 10 Feb 2026.
Copyright: © 2026 Du, Yerebake, Shi, Zhao, 李, Wan, Wang and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jun Wang
Chao-Qun Yan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.